News Focus
News Focus
Followers 8
Posts 178
Boards Moderated 0
Alias Born 12/10/2015

Re: ranchhand71 post# 1549

Wednesday, 02/03/2021 10:43:56 AM

Wednesday, February 03, 2021 10:43:56 AM

Post# of 3912
A Message from the AVXL message board

"Looks like a number of interested parties, whether retail or institutional, read with interest and understanding some of the postings I put a few days ago, telling (again) some of the unique, powerful Anavex science story lines. But, those are not just a story. Reality

Which fits, now, with the SAVA stuff. But, a close read and understanding of both mechanisms of action (MOAs) show that blarcamesine is much better, has multiple applications and therapeutic outcomes, compared to competitor's drug.

SAVA entered, is in the game, now (with their clinical results). AVXL, however, is the far stronger player; will rack up lots of points; will win the game --- perhaps on a TKO (technical, meaning real technology that works, knockout)".
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y